International Merchant Advisors to Develop Organic Science Branded Medical Marijuana Product Line
KINGWOOD, Texas, April 25 International Merchant Advisors, Inc. (Pink Sheets: IMAI) www.imaiinc.com announced today that its wholly owned subsidiary, California based Organic Science, Inc., intends to launch a national line of medical marijuana products under the Organic Science brand name. According to data provided in the new CNBC article "Marijuana and Money" www.cnbc.com, the medical marijuana national product market may be as large as $109 billion per year.
John Flinn, President of Organic Science, commented on the company's plans, "As the medical marijuana marketplace develops into a professional, nationwide business model, we believe that consistent quality and a predictable branded product will be critical to the success of dispensaries serving this community. Patients will want to depend on Organic Science products that give them the same predictable and effective result at an affordable price. We intend to develop the Organic Science brand as a national example of higher standards for the future growth of medical marijuana dispensaries and wellness centers throughout the USA in those states that medical marijuana is currently legal, such as California, Colorado, Montana, New Jersey, and others."
About International Merchant Advisors, Inc.
International Merchant Advisors, Inc. (IMAI) www.imaiinc.com is an international business banker and builder of companies focused on the development of Wellness Centers and Medical Marijuana clinics as a natural alternative for individuals suffering from chronic pain. IMAI intends to bring professional systems and controls to this highly fragmented mom and pop business, with medical supervision and legal compliance standards designed to raise the performance bar for those entering this highly regulated business segment. The company will acquire existing businesses, license and develop new clinics, and will act as an operations manager for non profit entities that dispense medical marijuana.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.
SOURCE International Merchant Advisors, Inc.
You May Also Like